Posted by Quintal on December 23, 2006, at 16:42:01
In reply to Amisulpride - lots of hype!, posted by jimmygold70 on December 23, 2006, at 16:06:05
Have you actually tried amisulpride jimmygold70? Both blueberry and I have and for me at least amisulpride was very different from other low-dose antipsychotics. There is good reason to think low dose amisulpride would be different from other antipsychotics because it *enhances* dopaminergic transmission. This gives amisulpride a different profile to other antipsychotics which are mostly dopamine antagonists across the dose range - Abilify is partial agonist at D2 receptors.
I appreciate your point of view, but that was a very strong statement with little to support it. Please try not to make other people feel put down.
Q
poster:Quintal
thread:715838
URL: http://www.dr-bob.org/babble/20061217/msgs/716004.html